Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:34 pm Sale | 2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -98,400 (Position Closed) | Filing History |
| 2025-02-14 5:22 pm Purchase | 2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | Anson Funds Management LP | 411,681 2.100% | 346,111 (+527.85%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | Perceptive Advisors LLC | 86,666 0.400% | 86,666 (New Position) | Filing History |
| 2024-11-14 5:52 pm Purchase | 2024-09-30 | 13G | Ensysce Biosciences, Inc. ENSC | Anson Funds Management LP | 65,570 7.100% | 65,570 (New Position) | Filing History |
| 2024-11-06 4:15 pm Purchase | 2024-10-30 | 13G | Ensysce Biosciences, Inc. ENSC | RA CAPITAL MANAGEMENT L.P. | 98,400 9.900% | 98,400 (New Position) | Filing History |
| 2024-10-29 5:27 pm Purchase | 2024-10-22 | 13G | Ensysce Biosciences, Inc. ENSC | Perceptive Advisors LLC | 86,667 8.700% | 86,667 (New Position) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | Lincoln Park Capital Fund LLC | 8,267 3.792% | -72 (-0.86%) | Filing History |
| 2023-07-17 6:15 pm Purchase | 2022-12-09 | 13D | Ensysce Biosciences, Inc. ENSC | GOWER BOB G | 10,772 5.700% | 10,772 (New Position) | Filing History |
| 2023-02-14 5:21 pm Sale | 2022-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | HG Vora Capital Management, LLC | 1,321 2.100% | -660 (-33.31%) | Filing History |
| 2023-02-14 11:20 am Sale | 2022-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | CVI Investments, Inc. | 1,872 4.900% | -906 (-32.63%) | Filing History |
| 2023-02-06 6:34 pm Purchase | 2023-02-02 | 13G | Ensysce Biosciences, Inc. ENSC | Lincoln Park Capital Fund LLC | 8,339 9.990% | 8,339 (New Position) | Filing History |
| 2022-12-16 10:24 am Purchase | 2022-12-07 | 13G | Ensysce Biosciences, Inc. ENSC | CVI Investments, Inc. | 2,778 7.800% | 2,778 (New Position) | Filing History |
| 2022-07-07 09:08 am Unchanged | 2022-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | Silvers Daniel B. | 801 7.900% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:46 pm Sale | 2021-12-31 | 13G | Leisure Acquisition Corp. LACQ | Glazer Capital, LLC | 0 0.000% | -18,932 (Position Closed) | Filing History |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | Ensysce Biosciences, Inc. ENSC | HG Vora Capital Management, LLC | 1,981 24.600% | 1,981 (New Position) | Filing History |
| 2021-10-12 4:15 pm Unchanged | 2021-10-07 | 13D | Ensysce Biosciences, Inc. ENSC | Silvers Daniel B. | 801 11.080% | 0 (Unchanged) | Filing History |
| 2021-07-12 4:40 pm Purchase | 2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | Wright Richard Chester | 385 5.400% | 385 (New Position) | Filing History |
| 2021-07-12 4:39 pm Purchase | 2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | Chang William H | 721 10.700% | 721 (New Position) | Filing History |
| 2021-07-12 4:37 pm Purchase | 2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | GOWER BOB G | 2,202 32.600% | 2,202 (New Position) | Filing History |
| 2021-07-12 4:35 pm Purchase | 2021-06-30 | 13D | Ensysce Biosciences, Inc. ENSC | Kirkpatrick Lynn | 723 9.800% | 723 (New Position) | Filing History |